Teleflex Acquires Palette Life Sciences
October 10, 2023
Teleflex Incorporated completed its acquisition of Palette Life Sciences AB for $600 million in upfront cash plus up to $50 million in potential milestone payments. The deal adds Palette’s NASHA-based products — including the Barrigel rectal spacer, Deflux and Solesta — to Teleflex’s interventional urology portfolio; Palette’s standalone net revenue was expected to be about $56 million for 2023.
- Buyers
- Teleflex Incorporated
- Targets
- Palette Life Sciences AB
- Industry
- Medical Devices
- Location
- Sweden
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.